MASH / MASLD

>

The HCPLive MASH & MASLD page is a comprehensive resource for clinical news and insights on metabolic dysfunction-associated steatotic liver disease and steatohepatitis. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for fatty liver disease, steatohepatitis, and more.

Latest News

The HCPFive: Top News for Healthcare Providers from the Week of 1/26
The HCPFive: Top News for Healthcare Providers from the Week of 1/26

February 1st 2025

Our top 5 headlines include approvals for a non-opioid pain reliever, the latest indication for semaglutide, positive phase 2 data in MASH, and more.

Lei Fan, MD, PhD, MPH | Credit: Vanderbilt University Medical Center
Poor Magnesium Status Linked to Greater Mortality Risk in Patients with MASLD, MetALD

January 31st 2025

Yasaman Vali, MD, PhD | Credit: Amsterdam UMC
Adjusted NIT Thresholds Needed for MASLD Fibrosis Detection in Clinical Practice

January 31st 2025

Giada Sebastiani, MD | Credit: McGill University
MASLD, Metabolic Risk Factors Linked to Fibrosis Progression in HCV

January 29th 2025

Steven Nissen, MD | Credit: Cleveland Clinic
Metabolic Surgery Improves Long-Term Liver Outcomes in MASH-Related Cirrhosis

January 28th 2025

© 2025 MJH Life Sciences

All rights reserved.